This month, the markets were extremely resilient, as they shrugged off profuse negative economic data to finish the month in positive territory. For the first time since October 2007, the Dow Jones Industrial Average, S&P 500 and NASDAQ all finished higher, improving 4.5%, 4.8% and 5.9%, respectively. Investors seemed primarily focused on several positive earnings […]
Company Announcements The Fraunhofer IBMT will develop new, customized applications for Magritek’s Kea NMR Mole System and will provide technical support for them in Europe. The companies will also work together on future developments of the system. Product Introductions Chenomx released Chenomx NMR Suite 5.0, a set of integrated software applications for performing NMR-based metabolomics. […]
Before the digital and automation age, cell counting was performed by using a microscope paired with a hemocytometer. While this decades-old manual method is still being utilized by labs, the primary advantage of this technique is its low cost. Its many drawbacks include a lack of precision, low accuracy, lot-to-lot variability and labor intensiveness. In […]
Metals: In 2007, mergers and acquisitions (M&A) activity in the metals industry increased 67% to $144.7 billion. Aluminum deals represented 56 of the year’s 411 disclosed transactions and amounted to $77.3 billion, almost four times the $21.3 billion spent on aluminum deals between 2003 and 2006. This increase was primarily due to Rio Tinto’s $38.1 […]
Company Announcements Invitrogen and PamGene will co-market Invitrogen’s Nuclear Hormone Receptor proteins and Lanthascreen assay technology with PamGene’s PamChip and PamStation Nuclear Hormone Receptor screening tools. Clinical Data and Affymetrix entered into a marketing agreement for a new drug metabolism service. Source BioScience will exclusively distribute Empire Genomics’ ACCUarray CGH genotyping technology in the UK. […]
As the largest market for particle size and distribution analysis, the pharmaceutical industry accounted for approximately 15% of the sales of instruments and aftermarket products last year. Particle size is a crucial metric for the design, quality control and manufacturing of pharmaceuticals. In developing new drugs, researchers are increasingly exploring the use of nano-sized particles […]
Company Announcements Environnement SA acquired Iséo, an environmental information systems company, in 2007, for €1 million ($1.4 million). Iséo had sales of €2.2 million ($2.8 million) in 2006. Ocimum Biosolutions raised $17 million from the Kubera Cross Border Fund in a Series B round of financing. Clemex Technologies announced in January that it is reviewing […]
R&D spending may be on the rise in Turkey due to a new measure that lets companies deduct all of their R&D spending from their tax base until 2024, an increase from the previously allowed 40% tax deduction. The law was passed to stimulate exports of technological products and to attract multinational R&D. To be […]
In regards to corporate earnings, most investors focus their attention on sales and either net income or earnings per share (EPS). While sales figures are usually straightforward, EPS results are often reported in both GAAP (Generally Accepted Accounting Principles) and nonGAAP adjustments. GAAP results provide a standardized and consistent method to compare results, but do […]
Going into this year’s Analytica, the confidence level for a successful event was not particularly high, as signs of negativity seemed unmistakable. After all, talks of a recession in the US and the low dollar could deter many US-based companies from attending the show. The previous Analytica, which was two years ago (see IBO 4/30/06), […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
